marginal significanceP = 0.056
Recipients who sustained a MACE (group B) compared to recipients with no MACE (group A) post transplantation had a significantly higher mean age (59 years vs 52 years, P < 0.001), had a higher prevalence of CVD before transplantation (44.4% vs 15%, P < 0.001) and, with a marginal significance, were more likely to be men (77.8% vs 61.2%, P = 0.056) (Table 1 ).